Medicine · 2025
Clinical characteristics and management of co-infected patients of influenza A and Aspergillus: Case series in the Southern China.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Chongxiang, Wang Pingping, Peng Ping
Аннотация
RATIONALE: Influenza and Aspergillus co-infection is a topic of significant interest.
PATIENT CONCERNS AND DIAGNOSES: We report 5 patients with influenza and Aspergillus co-infection of. Upon admission, all patients were diagnosed with influenza A virus infection and had elevated levels of inflammatory markers, including C-reactive protein and serum amyloid A.
INTERVENTIONS: The patients were treated with antiviral therapy upon admission. Computed tomography imaging 5 to 10 days later detected no improvement. Further investigation indicated that these patients exhibited signs of acute Aspergillus infection, showing halo signs and solidification along the bronchi. One patient was diagnosed with a co-infection by biopsy, while the remaining patients were diagnosed clinically based on at least 2 diagnostic markers (such as blood/BALF GM, tNGS, and sputum culture). After co-infection diagnosis, treatment was supplemented by the antifungal voriconazole.
OUTCOMES: Follow-up computed tomography scans in 4 patients revealed improvement after 7 to 14 days of antifungal treatment.
LESSONS: It is important to note that Aspergillus infection should be considered as a potential risk factor among patients with influenza who fail to improve or worsen despite receiving full antiviral treatment.
PATIENT CONCERNS AND DIAGNOSES: We report 5 patients with influenza and Aspergillus co-infection of. Upon admission, all patients were diagnosed with influenza A virus infection and had elevated levels of inflammatory markers, including C-reactive protein and serum amyloid A.
INTERVENTIONS: The patients were treated with antiviral therapy upon admission. Computed tomography imaging 5 to 10 days later detected no improvement. Further investigation indicated that these patients exhibited signs of acute Aspergillus infection, showing halo signs and solidification along the bronchi. One patient was diagnosed with a co-infection by biopsy, while the remaining patients were diagnosed clinically based on at least 2 diagnostic markers (such as blood/BALF GM, tNGS, and sputum culture). After co-infection diagnosis, treatment was supplemented by the antifungal voriconazole.
OUTCOMES: Follow-up computed tomography scans in 4 patients revealed improvement after 7 to 14 days of antifungal treatment.
LESSONS: It is important to note that Aspergillus infection should be considered as a potential risk factor among patients with influenza who fail to improve or worsen despite receiving full antiviral treatment.